S. African regulator approves Merck’s anti-COVID pill

S. African regulator approves Merck’s anti-COVID pill

South Africa’s health products regulator said on Friday it had approved the use of Merck’s COVID-19 pill for high-risk adults.

Comments are closed.

Organ-on-chip system enables precise monitoring of 3D tumour tissue outside the body

17 February 2022

Cellular waste disposal study provides new insights into Parkinson’s and Alzheimer’s

17 February 2022